What investigations are recommended for evaluating a patient with suspected rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Investigations for Suspected Rheumatoid Arthritis

Order anti-citrullinated protein antibodies (ACPA/anti-CCP) and rheumatoid factor (RF) as your primary serologic tests, along with C-reactive protein (CRP) and baseline X-rays of hands, wrists, and feet—these form the core diagnostic workup for suspected RA. 1, 2

Essential Laboratory Tests

Serologic Markers

  • Test both RF and ACPA (anti-CCP) in all patients presenting with synovitis, as these are the cornerstone autoantibodies for RA diagnosis 3, 1
  • ACPA has superior specificity (90%) with moderate sensitivity (60%), making it particularly valuable for confirming the diagnosis 3
  • RF has comparable sensitivity (60-80%) but lower specificity (70%), increasing to approximately 80% with prolonged disease 3
  • Negative RF and ACPA do not exclude RA—30-40% of RA patients are seronegative 2, 4
  • High-positive RF or high-positive ACPA scores 3 points in the 2010 ACR/EULAR classification criteria, while low-positive results score 2 points 3

Acute Phase Reactants

  • Measure CRP at baseline for both diagnosis and prognosis 3, 1
  • CRP is preferred over ESR because it is simpler, more reliable, and not age-dependent 3
  • Measuring both CRP and ESR offers no additional clinical value 3
  • Abnormal CRP or ESR scores 1 point in the classification criteria 3
  • Note that 40% of RA patients have normal acute phase reactants, so normal values do not exclude the diagnosis 4

Imaging Studies

Plain Radiography

  • Obtain X-rays of hands, wrists, and feet at baseline as the initial imaging method of choice 3, 1
  • The presence of erosions is predictive for RA development and disease persistence, scoring 5 points in classification criteria if erosions are present 3
  • Repeat X-rays within 1 year to assess progression 3
  • Early radiographic features include soft tissue swelling and juxtaarticular osteoporosis 5

Advanced Imaging (When Indicated)

  • MRI of hands and wrists can be considered when RA is suspected but clinical findings are inconclusive 3, 1
  • MRI can identify synovitis, bone edema, and erosions not evident on clinical examination or plain films 3
  • Ultrasound can detect synovial thickening even within finger joints, improving early assessment 5
  • Routine use of MRI and ultrasound is not recommended due to insufficient evidence for diagnosis or prognosis in undifferentiated arthritis 3

Clinical Assessment Components

Joint Examination

  • Perform a 28-joint count including proximal interphalangeal joints (1st-5th), metacarpophalangeal joints (1st-5th), wrists, elbows, shoulders, and knees bilaterally 3
  • Document the number of tender and swollen joints systematically 3
  • Small joint involvement (1-3 joints) scores 2 points, 4-10 small joints scores 3 points, and >10 joints including at least 1 small joint scores 5 points 3

Patient-Reported Outcomes

  • Assess morning stiffness duration (>30 minutes suggests inflammatory arthritis) 3
  • Measure pain using visual analog scales 3
  • Obtain patient Global Assessment of Disease Activity score 3
  • Evaluate functional status with Health Assessment Questionnaire Disability Index 3

Additional Baseline Tests

  • Complete blood count with differential to assess for anemia and other hematologic abnormalities 6
  • Renal and hepatic function tests before initiating disease-modifying therapy 6
  • Consider HLA-B27 testing only in specific clinical settings if axial or entheseal involvement suggests spondyloarthropathy rather than RA 3

Critical Pitfalls to Avoid

  • Do not delay referral to rheumatology based on negative RF or normal acute phase reactants—refer urgently if small joints of hands/feet are affected, multiple joints are involved, or symptoms persist ≥3 months 1, 2, 7
  • Do not routinely perform synovial biopsy; reserve this for persistent monoarthritis when differential diagnosis is unclear 3
  • Do not order genetic testing routinely, as no genetic test can be recommended for standard RA diagnosis 3
  • Remember that distal interphalangeal joints, sacroiliac joints, and lumbar spine are rarely involved in RA—their involvement suggests alternative diagnoses 5

Scoring for Classification

A score of ≥6/10 on the 2010 ACR/EULAR criteria establishes definite RA classification in patients with at least one joint showing definite clinical synovitis not better explained by another disease 3. The scoring includes:

  • Joint involvement (0-5 points based on number and size of joints)
  • Serology (0-3 points for RF and ACPA results)
  • Acute phase reactants (0-1 point for abnormal CRP or ESR)
  • Symptom duration (1 point if ≥6 weeks) 3

References

Guideline

Diagnostic Approach for Suspected Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Tests for Diagnosis and Management of Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical features of rheumatoid arthritis.

European journal of radiology, 1998

Research

Diagnosis and management of rheumatoid arthritis.

American family physician, 2011

Guideline

Management of Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.